March 2019 Teleconference

Vital Signs logo near handset and word bubble with 3 people in it

Staph Infections Can Kill: Prevention at the Front Lines

March 12, 2019 • 2:00 to 3:00 PM (EDT)

Get Email Updates

Vital Signs Logo near telephone handset next to word bubble with 3 people in it

Assistance

This teleconference has ended. Please send questions or concerns to CSTLTSfeedback@cdc.gov.

Agenda

Time Agenda Item Speaker(s)
2:00pm Welcome & Introduction José T. Montero, MD, MHCDS
Director, Center for State, Tribal, Local, and Territorial Support, CDC
2:05pm Vital Signs Overview Athena P. Kourtis, MD, PhD, MPH
Medical Officer, Associate Director for Data Activities, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC
2:15pm Presentations Marion Kainer, MD, MPH, FRACP, FSHEA
Director, Healthcare Associated Infections and Antimicrobial Resistance Program, Tennessee Department of Health
Martin E. Evans, MD
Director, Veteran’s Health Administration MRSA/MDRO Prevention Initiative, National Infectious Diseases Service; Professor Emeritus, Infectious Diseases, University of Kentucky School of Medicine
Susan Huang, MD, MPH
Professor of Medicine, Division of Infectious Diseases and Health Policy Research Institute, University of California, Irvine School of Medicine; Medical Director, Epidemiology and Infection Prevention, UC Irvine Health
2:40pm Q&A and Discussion Dr. José T. Montero
3:00pm End of call
Speakers' Biographies

Portrait image of Athena P. KourtisAthena P. Kourtis, MD, PhD, MPH

Medical Officer, Associate Director for Data Activities, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC)

Dr. Athena Kourtis currently serves as a medical officer and associate director for data activities in the Division of Healthcare Quality Promotion within CDC’s National Center for Emerging and Zoonotic Infectious Diseases. Dr. Kourtis, board-certified in pediatrics and in pediatric infectious diseases, is also a professor of pediatrics at Emory University. In addition to being a fellow of the American Academy of Pediatrics and a member of the Pediatric Infectious Diseases Society, she has served in various capacities in both of these associations. Dr. Kourtis has authored more than 180 peer-reviewed publications, editorials, and book chapters. She also has led several domestic and international clinical trials on child and adolescent health. Dr. Kourtis holds a PhD in immunology from the Pasteur Institute and an MPH from the Johns Hopkins Bloomberg School of Public Health.

Portrait of Marion A. Kainer, MD, MPH, FRACP, FSHEAMarion A. Kainer, MD, MPH, FRACP, FSHEA

Director, Healthcare Associated Infections and Antimicrobial Resistance Program, Tennessee Department of Health

Dr. Kainer is an adult infectious diseases physician and healthcare epidemiologist. In 2003, she joined the Tennessee Department of Health as director of the Healthcare Associated Infections and Antimicrobial Resistance Program. She works very closely with the Tennessee State Public Health Laboratory that serves as the South East Regional Laboratory for the Antibiotic Resistance Laboratory Network. She chairs the Healthcare Associated Infections (HAI) subcommittee of the Council of State and Territorial Epidemiologists (CSTE) and co-chairs the CSTE HAI Data Standards Committee and the Council for Outbreak Response: Healthcare Associated Infections and Antimicrobial Resistant Pathogens (CORHA). Previously, Dr. Kainer served as an Epidemic Intelligence Service officer at the Centers for Disease Control and Prevention (CDC) in the Division of Healthcare Quality Promotion. Dr. Kainer earned her medical degree and master of public health in Melbourne, Australia.

Portrait image of Martin E. Evans, MDMartin E. Evans, MD

Director, Veteran’s Health Administration (VHA) MRSA/MDRO Prevention Initiative, National Infectious Diseases Service; Professor Emeritus, Infectious Diseases, University of Kentucky School of Medicine

Dr. Martin Evans practiced clinical infectious diseases/infection control in the U.S. Air Force and performed bench-level research at the Uniformed Services University in Bethesda, Maryland. Later, he served as hospital epidemiologist/infectious diseases clinician at the University of Kentucky in Lexington. Dr. Evans also served as associate director of the national VHA MRSA Prevention Initiative and, since 2010, has been managing and reporting on the initiative as its director. Dr. Evans organized and implemented the VHA Clostridium difficile (C. difficile) Prevention Initiative in 2012 with the help of colleagues in the Veteran’s Administration and CDC. Because of this initiative, there has been a 30% decrease nationwide in C. difficile healthcare-associated infections in acute care facilities. In 2015, Dr. Evans organized and launched the carbapenem-resistant Enterobacteriaceae (CRE) Prevention Initiative. He administers the VHA MRSA, C. difficile, and CRE Prevention Initiatives and monitors their progress. In addition, he continues to support and collaborate with investigators in VHA who are examining novel approaches for the control of multidrug-resistant organisms and the diseases they cause.

Portrait image of Susan Huang, MD, MPHSusan Huang, MD, MPH

Professor of Medicine, Division of Infectious Diseases and Health Policy Research Institute, University of California (UC), Irvine School of Medicine; Medical Director, Epidemiology and Infection Prevention, UC Irvine Health

Dr. Susan Huang is the medical director of epidemiology and infection prevention at the University of California, Irvine School of Medicine. She’s also a professor of medicine in the Division of Infectious Diseases and Health Policy Research Institute there. For nearly 20 years, Dr. Huang has studied healthcare-associated infections with a focus on multidrug-resistant organisms (MDROs). Her research aims to identify the burden and risk factors for acquisition and disease and preventative strategies for containment. Dr. Huang has led several randomized clinical trials to prevent methicillin-resistant Staphylococcus aureus (MRSA) disease and other healthcare-associated infections. She also studies the regional prevention of MDROs in hospitals and nursing homes through epidemiologic studies as well as simulation models. Dr. Huang has authored 150 publications in peer-reviewed journals, and has served as a member of the Healthcare Infection Control Practices Advisory Committee (HICPAC), the CDC Antibiotic Resistance Working Group, and the Antibiotic Resistance Committee for the Infectious Diseases Society of America. She received her medical degree from Johns Hopkins School of Medicine and her master’s degree in quantitative methods from the Harvard School of Public Health.

Page last reviewed: March 21, 2019